Support for a national consortium for translational medical technology and pharmaceuticals research and training.
The Accelerating Australia project is set to improve coordination and collaboration across the sector by bringing together a consortium of members including government, industry organisations, service providers, universities and research institutes from across Australia to partner to provide a coordinated and streamlined range of training programs at a variety of levels across the continuum, catering to a broad range of participant requirements.
It will improve the management and workforce skills that are essential for growth of the sector via assembling an extensive mentorship group including industry professionals with high level expertise in intellectual property, clinical trial design and costs, venture capital, financial services, regulatory affairs, medicinal chemistry, and large pharma, as well as those with expertise in health economics, reproducibility of research, high throughput screening, preclinical testing, protocol development, biologics, toxicology, pharmacokinetics, repurposing molecules and working with university technology transfer offices.
Visit Accelerating Australia for more details.
LinkedIn: Accelerating Australia
|Consortium lead||Centre for Entrepreneurial Research and Innovation (CERI)|
|Consortium members|| |
The University of Western Australia, Monash University, University of Sydney, SPARK Co-Lab Ltd, University of Technology Sydney, Proteomics International Limited, Orthocell Ltd, St John of God Healthcare, Avita Medical, The University of Adelaide, Murdoch University, Curtin University, Edith Cowan University, Harry Perkins Institute of Medical Research, Telethon Kids Institute, Lions Eye Institute, Ear Science Institute Australia, Perron Institute for Neurological and Translational Science
|Project duration||March 2017 - March 2018|
|Contact||Kevin Pfleger, Harry Perkins Institute of Medical Research - email@example.com|